A Covid-19 Success, 300 Percent Stock Price Increase and the California Stem Cell Agency
A company that the California stem cell agency has backed with nearly $18 million scored big this morning on news that one of its products had generated a 100 percent survival rate with a small group of critically ill Covid-19 patients.
The company is Capricor, Inc., a publicly traded company based in Beverly Hills, Ca. Its stock soared more than 320 per…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.